Thomas Flaten

Q: What is Thomas Flaten's success rate?

Thomas Flaten currently has a success rate of 73.64335759552095.

Q: What is the average return of Thomas Flaten's calls?

Their stock ratings have generated an average return of 19.641283015154166.

Lake Street | Healthcare

Thomas Flaten is an analyst from Lake Street specializing in the Healthcare sector. Ranked #2122 out of 4773 analysts, they have issued 15 stock ratings with a success rate of 73.64% and an average return of 19.64%.

With 15 ratings to date, Thomas Flaten is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 73.64% and an average return of 19.64%, highlighting promising potential as their track record develops further.

#2122

Out of 4773

Total Ratings

+73.64%

Success Rate

+19.64%

Average Return

Recent Ratings Analysis

BLFS

Hold

Jul 22, 2026

Target

$31.00

Current

$34.95

Performance

12.20%

Thomas Flaten rated BLFS as Hold on Jul 22, 2026, setting a price target of 31. Despite the Hold call, shares climbed 12.20% to 34.95, revealing unexpected momentum.

PSNL

Hold

Jul 20, 2026

Target

$16.25

Current

$16.21

Performance

21.51%

On Jul 20, 2026, PSNL was given a Hold rating by Thomas Flaten, with a target price of 16.25. The stock rallied from 16.21 to 16.21 after the Hold rating, surprising to the upside.

VANI

Buy

Jun 23, 2026

Target

$4.00

Current

$1.27

Performance

6.72%

VANI received a Buy rating from Thomas Flaten on Jun 23, 2026, aiming for 4. Momentum has favored the Buy call, with shares climbing from 1.27 to 1.27, rewarding those who trusted the recommendation.

RPID

Buy

May 22, 2026

Target

$7.00

Current

$1.23

Performance

-40.00%

On May 22, 2026, Thomas Flaten published a Buy outlook on RPID, with a target of 7. Market action contradicted the Buy thesis, as shares slipped to 1.23.

MDXH

Buy

May 14, 2026

Target

$5.00

Current

$0.70

Performance

-28.45%

Thomas Flaten on May 14, 2026 assigned MDXH a Buy rating, with a price target of 5. The call has struggled to gain traction, with shares losing 28.45%.

ASRT

Hold

May 13, 2026

Target

$23.50

Current

$23.50

Performance

0.77%

On May 13, 2026, Thomas Flaten reaffirmed ASRT with a Hold rating, targeting 23.5. The neutral call matched muted market action of 0.77%.

EVAX

Buy

Mar 09, 2026

Target

$11.00

Current

$3.13

Performance

1.62%

EVAX was rated Buy by Thomas Flaten on Mar 09, 2026, with a price objective of 11. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

IMDX

Buy

Feb 17, 2026

Target

$12.00

Current

$4.20

Performance

-22.08%

On Feb 17, 2026, Thomas Flaten initiated coverage on IMDX with a Buy rating and target of 12. The Buy call has yet to be validated as shares remain 7.80 away from the target.

CSTL

Buy

Jan 12, 2026

Target

$52.00

Current

$32.33

Performance

-18.48%

Thomas Flaten issued a Buy recommendation for CSTL on Jan 12, 2026, price target set at 52. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

PTHS

Buy

Dec 03, 2025

Target

$50.00

Current

$21.90

Performance

-16.41%

On Dec 03, 2025, PTHS was evaluated by Thomas Flaten, who gave a Buy rating and target of 50. Investors saw limited payoff as shares fell short of the 50 target.

CNTB

Buy

Dec 01, 2025

Target

$9.00

Current

$2.04

Performance

-26.35%

Thomas Flaten rated CNTB as Buy on Dec 01, 2025, setting a price target of 9. The stock has underperformed, dropping 26.35% despite the bullish target of 9.

HROW

Buy

Sep 29, 2025

Target

$70.00

Current

$34.48

Performance

-28.76%

On Sep 29, 2025, HROW was given a Buy rating by Thomas Flaten, with a target price of 70. Despite the Buy call, shares fell from 34.48 to 34.48, challenging the optimistic stance.

DERM

Buy

Aug 13, 2025

Target

$13.00

Current

$7.23

Performance

-0.28%

DERM received a Buy rating from Thomas Flaten on Aug 13, 2025, aiming for 13. Price action was muted, as shares hovered around 7.23 despite the bullish outlook.

DMAC

Buy

Jul 18, 2025

Target

$14.00

Current

$6.47

Performance

54.78%

On Jul 18, 2025, Thomas Flaten published a Buy outlook on DMAC, with a target of 14. Shares gained 54.78%, underscoring the accuracy of the bullish outlook toward 14.

AYTU

Buy

Jul 01, 2025

Target

$8.00

Current

$1.99

Performance

-11.95%

Thomas Flaten on Jul 01, 2025 assigned AYTU a Buy rating, with a price target of 8. The call has struggled to gain traction, with shares losing 11.95%.

OCX

Buy

May 21, 2025

Target

$8.00

Current

$3.20

Performance

4.23%

On May 21, 2025, Thomas Flaten reaffirmed OCX with a Buy rating, targeting 8. Market indecision has kept the 8 target in a holding pattern.

OPTN

Hold

Mar 20, 2025

Target

$9.00

Current

$9.60

Performance

4.92%

OPTN was rated Hold by Thomas Flaten on Mar 20, 2025, with a price objective of 9. Flat performance suggests the Hold view was reasonable.

CKPT

Hold

Mar 10, 2025

Target

$4.10

Current

$4.26

Performance

7.04%

On Mar 10, 2025, Thomas Flaten initiated coverage on CKPT with a Hold rating and target of 4.1. The Hold stance underestimated the stock’s strength as it gained 7.04%.

AQST

Buy

Mar 07, 2025

Target

$8.00

Current

$4.78

Performance

80.38%

Thomas Flaten issued a Buy recommendation for AQST on Mar 07, 2025, price target set at 8. Investors following the Buy call captured upside momentum, with shares now at 4.78.

Frequency Asked Questions

Who is Thomas Flaten?

Thomas Flaten is an analyst from Lake Street specializing in the Healthcare sector.

What is Thomas Flaten's success rate?

Thomas Flaten currently has a success rate of +73.64%.

How many ratings has Thomas Flaten issued?

Thomas Flaten has issued 15 stock ratings so far.

What is the average return of Thomas Flaten's calls?

Their stock ratings have generated an average return of +19.64%.

What is Thomas Flaten's ranking?

Thomas Flaten is ranked #2122 out of 4773 analysts.

What types of ratings does Thomas Flaten give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Thomas Flaten?

You can follow Thomas Flaten by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Thomas Flaten?

Their latest rating was a Hold on BLFS issued on 2026-07-22.